Enterprise Ireland clients share in over €10 million in EU funding
Four Enterprise Ireland clients and one client of Údarás na Gaeltachta have secured €10M from the European Union’s scientific research fund to help them get their big ideas to market:
- DP DesignPro Ltd of Abbeyfeale Co. Limerick was awarded €1.93M to develop new, affordable and reliable HydroKinetic turbines that can exploit the huge potential of clean, predictable energy in the world’s rivers, canals and estuaries (project name: DP Renewables).
- Luxcel Biosciences in Cork received €1.03M to develop advanced solutions for high sensitivity metabolism and toxicity assays (project name: MetaTox-HS).
- Axonista Ltd of Dublin secured €1.7M to work on a smart video app for smart devices (project name: Ediflo Pro).
- Slainte Beoga Teor of Galway and a client of Udaras na Gaeltachta, won €2.5M to develop a non-antibiotic antimicrobial treatment for Bovine Mastitis (project name: PanaMast).
- Altratech of Shannon received €2.97M for a portable battery-operated kit for the quick detection of the HIV virus (project name: Easiviral).
Dr. Imelda Lambkin, Enterprise Ireland and National Director of Horizon 2020 in Ireland congratulated the five Irish SMEs on their EU grants of up to 2.5 million each from the Horizon 2020 SME Instrument Phase 2 funding saying “This is a significant milestone in Ireland’s performance in Horizon 2020 and brings the total number of Irish SMEs to win funding from phase 2 of the SME Instrument to 26 since its launch in 2014. The funding is for innovative small firms to get ideas from the lab to the market and help generate growth and jobs in Europe. Enterprise Ireland, working closely with our partners in Ireland’s national support network for Horizon 2020 are encouraging more Irish SMEs to apply to the SME Instrument using the support and advice we provide”.
Each of the projects will receive up to €2.5 million to finance innovation activities. Thanks to the funding, the selected SMEs can finance innovation activities like demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product. The companies involved in the projects will also benefit from 12 days of business coaching.
Funding under Phase 2 of the instrument allows companies to invest in innovation activities such as demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product. The companies will also benefit from 12 days of business coaching. Most projects are proposed by a single SME but some companies team-up to elaborate a project.
The next cut-off for SME Instrument Phase 2 is on 6 April 2017.